Company Profiles

driven by the PitchBook Platform

Crititech

Description

Manufacturer of fine-particle compounds designed to micronize a wide variety of small-molecule and biotechnology drugs. The company develops fine-particle compounds that utilizes its proprietary CO2 technology to develop and manufacture differentiated drugs and medical devices for the human and animal health markets by optimizing delivery of challenging drug substances which includes potent molecules, poorly soluble compounds and bio-molecules with its ability to simplify formulations.

1997

Founded

PRIVATE

Status

11-50

Employees

Angel

Latest Deal Type

$5.9M

Total Amount Raised

6

Investors

Description

Manufacturer of fine-particle compounds designed to micronize a wide variety of small-molecule and biotechnology drugs. The company develops fine-particle compounds that utilizes its proprietary CO2 technology to develop and manufacture differentiated drugs and medical devices for the human and animal health markets by optimizing delivery of challenging drug substances which includes potent molecules, poorly soluble compounds and bio-molecules with its ability to simplify formulations.

Website:

www.crititech.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Delivery

Primary Office

1849 East 1450 Road Lawrence, KS 66044United States +1 (785) 841-7120
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Crititech's full profile, request a free trial.

Crititech Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Crititech Investors (6)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
National Institutes of HealthGovernment000 0000000 0000
Precede FundVenture CapitalMinority000 0000000 0000
SeedStep AngelsAngel GroupMinority000 0000000 0000
The TAC GroupCorporationMinority000 0000000 0000
Tony SchmidtAngel (individual)Minority000 0000000 0000
National Institutes of Health Government
Precede Fund Venture Capital
SeedStep Angels Angel Group
The TAC Group Corporation
Tony Schmidt Angel (individual)

Crititech Executive Team (8)

NameTitleBoard
Seat
Contact
Info
Matthew McClorey JDPresident & Board Member
Jeffrey MorrisonChief Financial Officer
Sam CampbellChairman, President & Chief Strategy Officer
Michael Baltezor Ph.DChief Scientific Officer
Jahna EspinosaDirector, Laboratory Operations
Matthew McClorey JD President & Board Member
Jeffrey Morrison Chief Financial Officer
Sam Campbell Chairman, President & Chief Strategy Officer
Michael Baltezor Ph.D Chief Scientific Officer
Jahna Espinosa Director, Laboratory Operations

Crititech Board Members (4)

NameRepresentingRoleSinceContact
Info
Bala Subramaniam Ph.DCrititechCo-Founder & Board Member000 0000
Matthew McClorey JDCrititechPresident & Board Member000 0000
Sam CampbellCrititechChairman, President & Chief Strategy Officer000 0000
William Duncan Ph.DSelfBoard Member000 0000
Bala Subramaniam Ph.D Co-Founder & Board Member Crititech
Matthew McClorey JD President & Board Member Crititech
Sam Campbell Chairman, President & Chief Strategy Officer Crititech
William Duncan Ph.D Board Member Self
Request full access to PitchBook